Literature DB >> 21641353

Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy.

Maria Rosa Conte1, Sergio Bongioanni, Amedeo Chiribiri, Stefano Leuzzi, Elisabetta Lardone, Paolo Di Donna, Alfredo Pizzuti, Stefania Luceri, Federico Cesarani, Barbara Mabritto, Giuseppe Biondi Zoccai, Rodolfo Bonamini, Fiorenzo Gaita.   

Abstract

BACKGROUND: Cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement (LGE) can identify areas of myocardial fibrosis in vivo in patients with hypertrophic cardiomyopathy (HCM). The aim of this study was to examine the association between clinical-morphological variables, risk factor for sudden death, and LGE findings in a consecutive, unselected population of HCM patients.
METHODS: From January 2005 to August 2009, 124 HCM patients (53 ± 17 years, 86 men) were prospectively evaluated with CMR examination, assessing left ventricular (LV) hypertrophy, function, and LGE.
RESULTS: In univariate analysis, patients were divided into tertiles according to the number of segments positive for LGE (first tertile, 0.3 ± 0.4; second tertile, 2.2 ± 0.4; third tertile, 5.2 ± 1.9 segments). Male gender (P = .05), maximum LV wall thickness (P = .002), nonsustained ventricular tachycardia (P = .001), ejection fraction <50% (P = .02), LV mass (P = .02), left atrium dilation (P = .04), perfusion defects (P ≤ .001), and telesystolic volume (P = .04) were all positively related with the number of segments of LGE. In multivariable analysis, male gender (P = .007), maximum LV wall thickness (P = .006), LV mass (P = .031), and perfusion alterations (P = .017) were independent predictors of LGE extent.
CONCLUSIONS: Our study shows an independent association, even at multivariate analysis, between the entity of LGE and maximum LV wall thickness, mass, and perfusion defects in patients with HCM. Whether the presence and the extent of LGE translates into clinical events later on awaits further long-term follow-up studies.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641353     DOI: 10.1016/j.ahj.2011.03.022

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  The role of echocardiography in hypertrophic cardiomyopathy.

Authors:  Lynne K Williams; Christiane H Gruner; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2015-02       Impact factor: 2.931

2.  Sex-related differences in left ventricular remodeling and outcome after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: insights from cardiovascular magnetic resonance imaging.

Authors:  You-Zhou Chen; Xing-Shan Zhao; Jian-Song Yuan; Yan Zhang; Wei Liu; Shu-Bin Qiao
Journal:  Biol Sex Differ       Date:  2022-07-07       Impact factor: 8.811

3.  Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.

Authors:  Jennifer Mancio; Farhad Pashakhanloo; Hossam El-Rewaidy; Jihye Jang; Gargi Joshi; Ibolya Csecs; Long Ngo; Ethan Rowin; Warren Manning; Martin Maron; Reza Nezafat
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-03-22       Impact factor: 9.130

4.  Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death.

Authors:  A Chiribiri; S Leuzzi; M R Conte; S Bongioanni; K Bratis; L Olivotti; C De Rosa; E Lardone; P Di Donna; A D M Villa; F Cesarani; E Nagel; F Gaita; R Bonamini
Journal:  Clin Radiol       Date:  2015-02-07       Impact factor: 2.350

Review 5.  Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy.

Authors:  Juan Carlos Brenes; Adelina Doltra; Susanna Prat
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

6.  Preoperative myocardial fibrosis is associated with worse survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: A delayed enhanced cardiac magnetic resonance study.

Authors:  Youzhou Chen; Xingshan Zhao; Jiansong Yuan; Yan Zhang; Wei Liu; Shubin Qiao
Journal:  Front Cardiovasc Med       Date:  2022-08-11

7.  Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.

Authors:  Andris H Ellims; Leah M Iles; Liang-han Ling; James L Hare; David M Kaye; Andrew J Taylor
Journal:  J Cardiovasc Magn Reson       Date:  2012-10-29       Impact factor: 5.364

8.  Different Phenotypes of Anderson-Fabry Disease Identified with Cardiac Magnetic Resonance Imaging in a Family with the Same Late-Onset Mutation.

Authors:  Diego A Ávila-Sánchez; Esther Cambronero-Cortinas; Manuel Barreiro-Pérez; Juan L Rodríguez-Hernández; Brais Díaz-Fernández; Pedro L Sánchez
Journal:  Am J Case Rep       Date:  2020-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.